How to take NMN powder: dose, form, timing and supply

How do you take NMN powder? In human trials, 250 to 900 mg of NMN a day raised blood NAD+

How do you take NMN powder? In human trials, 250 to 900 mg of NMN a day raised blood NAD+, highest at 600 and 900 mg in a 60-day trial. One 0.5 g scoop holds 500 mg; a 100 g jar, 200 servings.

Reader-supported: this page has affiliate links to Renue By Science. If you buy through them we earn a commission, which funds our research. We choose what to cover independently. How we’re funded

Article info

Evidence: 8 papers, 7 human studies, 1 review.

  • A 7 human RCT, meta-analysis or systematic review
  • B 1 small, pilot or observational human study
Research and article information

How we made this. Checked against every study we cite. It is not medical advice.

Updated:

A translucent scoop filled with white powder rests on a metal weighing pan, with glassware behind it.
A portion of powder illustrates the guide to taking NMN powder.

The evidence

8

studies behind this article

7 human studies · 1 review

  • 7 study design grade A
  • 1 study design grade B

How do you take NMN powder, and how much? In human trials, 250 to 900 mg of NMN a day raised blood NAD+ (Morifuji 2024; Yi 2023). In a 60-day trial of 80 healthy middle-aged adults, NAD+ was highest at 600 and 900 mg, those groups walked furthest in a six-minute test, and blood biological age held steady on NMN while it rose on placebo (Yi 2023). Here is a routine built on what the trials gave participants: a daily amount inside the 250 to 1,200 mg they used (Liao 2021), once a day or split in two, in a form you can keep up, for 6 to 12 weeks. One 0.5 g scoop of NMN Pure Powder holds 500 mg. How much the NAD+ rise varies from person to person, and whether taking it under the tongue changes it over weeks, are the open points.

How people took it in the trials

The trials that tracked NAD+ over time gave NMN by mouth, every day, for 14 days to 12 weeks. Pick the form you can take every day.

A grey-haired man in a flannel shirt and slippers sits on a wooden back step, sipping from a white mug in soft morning sunlight over a dewy lawn.
Trial participants took NMN by mouth every day, so pick a form that fits your daily routine.

The dose. The human trials most often used 250 to 900 mg of NMN a day. In a 60-day trial of 80 healthy middle-aged adults, 300, 600 and 900 mg a day each raised blood NAD+ versus a dummy pill, with the highest levels, and the longest six-minute walks, at 600 and 900 mg (Yi 2023). In a 12-week trial of 60 older adults, 250 mg a day raised blood NAD+ and its metabolites above placebo (Morifuji 2024). A 6-week trial of 48 amateur runners went up to 1,200 mg a day (Liao 2021). Across a 2025 meta-analysis of 12 studies in 513 adults, NMN significantly raised blood NAD (Zhang 2025).

The form. No trial in our evidence compared powder with capsules or liposomes, so the choice between them is one of convenience and value. The one trial that compared routes, a crossover in 14 healthy men, found that taking NMN under the tongue (sublingually) raised two NAD+ by-products (2PY and 4PY) faster over the first 60 minutes than swallowing it, while blood NMN, nicotinamide and NAD+ did not differ between the two ways (Wakabayashi 2026). A capsule is the simpler habit; a powder lets you set the amount by the scoop.

The timing. The 60-day trial gave one dose a day (Yi 2023). A 12-week trial in 36 healthy middle-aged adults split 250 mg into 125 mg twice a day, and serum nicotinamide, a NAD+ metabolite, rose more than on placebo (Katayoshi 2023). No trial in our evidence compared times of day, so a time you can keep each day is the practical choice.

The weeks. Blood NAD+ rose within weeks: in a 14-day trial of 65 healthy adults, NMN and nicotinamide riboside (NR) comparably raised circulatory NAD+, while nicotinamide did not (Christen 2026), and in the 60-day trial NAD+ was already up at day 30 (Yi 2023). The trials that measured walking, aerobic capacity or sleep ran 6 to 12 weeks, so that is the window the evidence covers.

The studies ran from 2 weeks to 12 weeks

  • Christen 2026 not reported (NMN and NR compared)

    Measured: circulatory NAD+

  • Liao 2021 300/600/1,200 mg/day, plus training

    Measured: VO2 and power at thresholds

  • Yi 2023 300/600/900 mg once a day

    Measured: blood NAD+, six-minute walk

  • Katayoshi 2023 250 mg/day split into two doses

    Measured: NAD+ metabolite (nicotinamide)

  • Morifuji 2024 250 mg a day

    Measured: blood NAD+, 4-m walk, sleep quality

Figure 1. The dose each human trial used and how long it lasted, as its abstract reports. Longer bars mean longer trials.

Source: Healthspan Post summary of the cited trials (PubMed).

What the trials measured beyond NAD+

In the 60-day trial of 80 middle-aged adults, six-minute walking distance rose more on 300 to 900 mg of NMN than on placebo, self-rated health on the SF-36 survey was better in the NMN groups by day 60, and blood biological age held steady while it rose on placebo (Yi 2023). A follow-up analysis of that trial found that bigger NAD+ rises went with longer walks and better SF-36 scores (Kuerec 2024).

In a 12-week trial of 60 older adults on 250 mg a day, 4-meter walking time was shorter and sleep quality better than on placebo, though the main stepping test did not differ (Morifuji 2024).

In a 6-week trial of 48 amateur runners training 5 to 6 times a week, 600 and 1,200 mg a day raised oxygen uptake and power at the two ventilatory thresholds more than placebo; VO2max and peak power did not differ (Liao 2021).

In the 2025 meta-analysis, most glucose and lipid outcomes did not differ from control (Zhang 2025).

Who the trials did not cover

The trials enrolled adults. Pregnant or breastfeeding women and people under 18 were not studied. If you take prescription medicine, check with your clinician first.

Figure 2. The molecule is the same in every form; the form changes the dose format, convenience and cost per dose. Few human trials compare forms head to head.

Source: Healthspan Post, from product labels.

What is in the product

NMN Pure Powder holds 500 mg of NMN in one 0.5 g scoop, with no other ingredients, and a 100 g jar holds 200 servings. Renue lists it as a sublingual powder and says it supports NAD+ levels that help power your cells. Renue suggests one full scoop (500 mg) twice daily, starting with half a scoop twice daily for the first week if you are new to NMN. One scoop a day and two scoops a day both sit inside the 250 to 1,200 mg a day the trials used.

How long a 100 g jar lasts, from the label: about 400 days at 250 mg a day, about 333 days at 300 mg, 200 days at one scoop (500 mg), about 167 days at 600 mg, and 100 days at Renue’s suggested two scoops (1,000 mg).

For capsules, NMN Liposomal Capsules give 500 mg of NMN from two capsules over 45 servings, and Renue designs the liposomes for slower, more sustained release. For more in one capsule, NAD+ Complete is a four-in-one liposomal blend of NMN, NR, trigonelline and NAD+. For the NR route, NR Powder Smooth Taste Blend gives 1,000 mg of nicotinamide riboside per serving.

Ways to pay less

  • Subscribe & Save gives a 10% discount when you subscribe.
  • Some Renue pages list free shipping once an order passes a spending threshold.
  • Cost per dose for each product is on the site’s live price table.

Price per serving

ProductFormPer servingServingsPriceCost per servingCost per 500 mg
NMN Pure Powder by Renue By Science, current packaging
NMN Pure Powder500 mg per 0.5 g scoop, no other ingredients, 200 servings per 100 g; see the price table
sublingual powder500 mg200$54.95$0.27$0.27
NMN Liposomal Capsules by Renue By Science, current packaging
NMN Liposomal Capsules500 mg per two-capsule serving, 45 servings; liposomes designed for slower, sustained release; see the price table
liposomal capsule500 mg45$64.95$1.44$1.44
NAD+ Complete by Renue By Science, current packaging
NAD+ Complete310 mg NMN, 160 mg NAD+, 100 mg NR and 70 mg trigonelline per two-capsule serving; see the price table
liposomal capsule blendNMN 310 mg, NAD+ 160 mg, NR 100 mg and trigonelline 70 mg per 2 capsules60$84.95$1.42—

One-time purchase prices from Renue By Science, checked November 12, 2026. Prices change; the store shows the current one. Cost per 500 mg uses the main active ingredient.

Figure 3. NMN sits one step from NAD+ in the salvage pathway, the main route cells use to keep NAD+ topped up.

Source: Covarrubias et al., Nature Reviews Molecular Cell Biology, 2021 (PubMed 33353981).

Show the scienceStudy-by-study table: 8 studies, design, dose and grade

The evidence

Every study cited in this article. Grades: A human RCT, meta-analysis or systematic review; B small, pilot or observational human study.

StudyDesignPeopleDose / durationResultGradeSource
Yi 2023[1]RCT80 healthy middle-aged adultsn = 80300, 600 or 900 mg once a day, or placebo · 60 daysBlood NAD+ rose above placebo and baseline at days 30 and 60 in every NMN group, highest at 600 and 900 mg; six-minute walk distance rose more than placebo, longest at 600 and 900 mg; blood biological age held steady on NMN while it rose on placebo; no safety issues found.APubMed 36482258
Morifuji 2024[2]RCT60 older adultsn = 60250 mg a day, or placebo · 12 weeksBlood NAD+ and its metabolites were higher than placebo; 4-meter walking time was shorter; sleep quality was better; the primary stepping test did not differ; no adverse effects related to NMN.APubMed 38789831
Katayoshi 2023[3]RCT36 healthy middle-aged adultsn = 36125 mg twice a day (250 mg/day), or placebo · 12 weeksSerum nicotinamide, a NAD+ metabolite, was significantly higher than placebo; arterial-stiffness pulse-wave velocity trended down but did not differ significantly; well tolerated, no adverse events.APubMed 36797393
Wakabayashi 2026[4]RCT14 healthy adult men (randomized two-period crossover)n = 14single dose under the tongue and swallowed; amount not reported · single dose, 0-60 min sampling; 8-day washoutTwo NAD+ catabolites (2PY and 4PY) rose faster after sublingual than swallowed NMN over the first hour; blood NMN, nicotinamide and NAD+ did not differ between routes; no adverse events reported.APubMed 42304075
Liao 2021[5]RCT48 young and middle-aged amateur runnersn = 48300, 600 or 1,200 mg a day, or placebo, with 5-6 training sessions a week · 6 weeksVO2, %VO2max and power at both ventilatory thresholds rose more than control at 600 and 1,200 mg; VO2max, O2-pulse and peak power did not differ.APubMed 34238308
Kuerec 2024[6]cohort80 generally healthy adults aged 40-65 (post-hoc analysis of a randomized trial)n = 80300, 600 or 900 mg a day, or placebo · 60 daysNAD+ rose with dose, with large variation within each group (coefficient of variation 29.2-113.3%); bigger NAD+ rises were associated with longer six-minute walks and better SF-36 scores.BPubMed 38430946
Christen 2026[7]RCT65 healthy adultsn = 65not reported (NMN, nicotinamide riboside and nicotinamide compared) · 14 daysBoth NMN and nicotinamide riboside, but not nicotinamide, comparably increased circulatory NAD+; authors propose gut microbes may convert precursors to nicotinic acid.APubMed 41540253
Zhang 2025[8]meta-analysis12 studies of NMN in 513 adultsn = 513not reportedNMN significantly raised blood NAD overall; most clinically relevant outcomes (fasting glucose and lipids) did not differ from control; authors caution that benefits may be exaggerated in the field.APubMed 39116016

Questions readers ask

How much NMN is in one scoop of powder?

One 0.5 g scoop is 500 mg of nicotinamide mononucleotide, with no other ingredients. A 100 g jar holds 200 servings.

Should I take the dose once or split into two?

The trials used both patterns: 300, 600 or 900 mg once a day in a 60-day trial of 80 adults, and 125 mg twice a day (250 mg/day) in a 12-week trial of 36 adults. Both raised NAD+ measures. Renue suggests one full scoop (500 mg) twice daily, 1,000 mg a day, which sits inside the 250 to 1,200 mg a day the trials on this page used.

Does sublingual powder raise NAD+ more than swallowing it?

In a randomized crossover of 14 healthy men, two NAD+ by-products (2PY and 4PY) rose faster over the first hour after taking NMN under the tongue than after swallowing it, but blood NAD+ did not differ between the two ways. No trial on this page compared powder, capsules or liposomes. Source PubMed 42304075

Was NMN well tolerated at the higher trial doses?

In a 60-day trial of 80 healthy middle-aged adults, no safety issues were found at 300, 600 or 900 mg a day, based on adverse events and lab and clinical measures, and NMN was well tolerated. Source PubMed 36482258

How long will a 100 g jar last?

At 250 mg a day a 100 g jar lasts about 400 days; at 300 mg about 333 days; at one scoop (500 mg) 200 days; at 600 mg about 167 days; at two scoops (1,000 mg) 100 days. The longer trials on this page ran 6 to 12 weeks.

NMN Pure Powder: the trade-offs

Why people choose it

  • 500 mg NMN per scoop, 200 servings per 100 g
  • Plain NMN with no other ingredients listed
  • Can be swallowed in water, the way the NMN trials gave it

Things to know

  • You measure each scoop yourself

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Support our research

References

View all 8 cited studies
  1. Yi L, Maier AB, Tao R, et al. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. Geroscience. PubMed 36482258
  2. Morifuji M, Higashi S, Ebihara S, et al. (2024). Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study. Geroscience. PubMed 38789831
  3. Katayoshi T, Uehata S, Nakashima N, et al. (2023). Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial. Sci Rep. PubMed 36797393
  4. Wakabayashi J, Higashi S, Morifuji M (2026). Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men. Sci Rep. PubMed 42304075
  5. Liao B, Zhao Y, Wang D, et al. (2021). Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. PubMed 34238308
  6. Kuerec AH, Wang W, Yi L, et al. (2024). Towards personalized nicotinamide mononucleotide (NMN) supplementation: Nicotinamide adenine dinucleotide (NAD) concentration. Mech Ageing Dev. PubMed 38430946
  7. Christen S, Redeuil K, Goulet L, et al. (2026). The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nat Metab. PubMed 41540253
  8. Zhang J, Poon ET, Wong SH (2025). Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials. Crit Rev Food Sci Nutr. PubMed 39116016